3 latest FDA approvals

Here are the three latest drugs or medical devices approved by the Food and Drug Administration in the past week.

Advertisement

1. Verzenio is intended to treat adults with advanced or metastatic breast cancer that has progressed despite prior treatment.

2. FreeStyle Libre Flash Glucose Monitoring System is the first continuous glucose monitoring system that does not require adult patients to draw a blood sample from their fingertip.

3. The Ellipse implantable cardioverter defibrillator received MRI-compatible labeling.

More articles on supply chain:

AmerisourceBergen fined $260M over cancer drug packaging: 4 things to know
Millennials least likely to comply with recall notices, study finds
A proactive approach to drug shortages: 6 strategies from Advocate Health Care’s director of central service pharmacy

 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.